AAPL342.93-1.24 (-0.36%) ▼|ABBV290.03+1.79 (+0.62%) ▲|ABT110.28-3.32 (-2.92%) ▼|ACN260.63-4.53 (-1.71%) ▼|ADBE239.54-6.90 (-2.80%) ▼|AMAT332.68+13.43 (+4.21%) ▲|AMD448.79+44.39 (+10.98%) ▲|AMGN460.74+0.46 (+0.10%) ▲|AMT189.86-4.14 (-2.13%) ▼|AMZN261.44+1.23 (+0.47%) ▲|AVGO292.85+1.32 (+0.45%) ▲|AXP321.54-3.43 (-1.06%) ▼|BA173.05+0.55 (+0.32%) ▲|BAC49.82+0.06 (+0.11%) ▲|BKNG162.34-6.38 (-3.78%) ▼|BLK1,183.11+12.44 (+1.06%) ▲|BMY62.88-0.25 (-0.40%) ▼|BNY148.47+0.98 (+0.66%) ▲|BRK-B573.20+0.87 (+0.15%) ▲|C119.98+1.53 (+1.29%) ▲|CAT556.69+3.05 (+0.55%) ▲|CL97.08-1.61 (-1.63%) ▼|CMCSA24.61-0.34 (-1.36%) ▼|COF201.52-2.33 (-1.14%) ▼|COP136.82+1.36 (+1.00%) ▲|COST1,061.45-4.15 (-0.39%) ▼|CRM215.13-7.28 (-3.27%) ▼|CSCO93.51-2.21 (-2.30%) ▼|CVS83.60+2.27 (+2.79%) ▲|CVX213.88+0.95 (+0.45%) ▲|DE673.69+10.38 (+1.56%) ▲|DHR229.76+3.42 (+1.51%) ▲|DIS117.22+0.00 (+0.00%) ▲|DUK128.65-1.43 (-1.10%) ▼|EMR161.75-0.87 (-0.53%) ▼|FDX308.12-8.69 (-2.74%) ▼|GD355.04-1.31 (-0.37%) ▼|GE322.41+7.68 (+2.44%) ▲|GEV759.68-10.83 (-1.41%) ▼|GILD168.07+0.50 (+0.30%) ▲|GM87.41-1.92 (-2.15%) ▼|GOOG284.24+2.50 (+0.89%) ▲|GOOGL285.31+2.74 (+0.97%) ▲|GS874.10+5.15 (+0.59%) ▲|HD344.50-5.45 (-1.56%) ▼|HON220.00+4.22 (+1.96%) ▲|IBM244.28-2.83 (-1.15%) ▼|INTC55.93+3.68 (+7.04%) ▲|INTU341.10-13.74 (-3.87%) ▼|ISRG454.33-14.20 (-3.03%) ▼|JNJ275.26+2.94 (+1.08%) ▲|JPM336.59-0.75 (-0.22%) ▼|KO96.27+0.54 (+0.56%) ▲|LIN518.36-2.87 (-0.55%) ▼|LLY1,368.38+3.65 (+0.27%) ▲|LMT571.98-4.18 (-0.73%) ▼|LOW225.22-2.02 (-0.89%) ▼|LRCX198.72+13.52 (+7.30%) ▲|MA657.52+1.60 (+0.24%) ▲|MCD277.65-0.39 (-0.14%) ▼|MDLZ66.50-0.32 (-0.48%) ▼|MDT102.58-2.26 (-2.16%) ▼|META617.42+12.34 (+2.04%) ▲|MMM187.05-0.72 (-0.38%) ▼|MO76.59-0.99 (-1.28%) ▼|MRK147.10+0.16 (+0.11%) ▲|MS183.12+0.68 (+0.37%) ▲|MSFT532.75-3.18 (-0.59%) ▼|MU682.73+26.34 (+4.01%) ▲|NEE87.54-0.72 (-0.81%) ▼|NFLX63.76-1.81 (-2.75%) ▼|NKE38.62-0.94 (-2.38%) ▼|NOW102.10-0.26 (-0.25%) ▼|NVDA185.84+4.24 (+2.34%) ▲|ORCL113.65-1.52 (-1.32%) ▼|PEP141.61-1.10 (-0.77%) ▼|PFE29.30-0.16 (-0.53%) ▼|PG166.01-1.09 (-0.65%) ▼|PLTR160.16+5.17 (+3.34%) ▲|PM199.55-1.96 (-0.97%) ▼|QCOM164.01+7.26 (+4.63%) ▲|RTX192.59+0.71 (+0.37%) ▲|SBUX105.79-0.37 (-0.35%) ▼|SCHW91.56-1.02 (-1.10%) ▼|SO92.48-0.87 (-0.93%) ▼|SPG228.46+1.91 (+0.84%) ▲|T21.70-0.12 (-0.55%) ▼|TMO696.33+19.39 (+2.86%) ▲|TMUS160.37-0.23 (-0.14%) ▼|TSLA358.50+14.81 (+4.31%) ▲|TXN275.91-2.24 (-0.81%) ▼|UBER69.02+0.24 (+0.35%) ▲|UNH394.96-0.77 (-0.19%) ▼|UNP291.92-6.04 (-2.03%) ▼|UPS108.31-2.73 (-2.46%) ▼|USB59.40-0.36 (-0.59%) ▼|V423.28+0.69 (+0.16%) ▲|VZ45.87-0.26 (-0.55%) ▼|WFC84.12-0.18 (-0.21%) ▼|WMT126.24-1.48 (-1.16%) ▼|XOM166.12+0.82 (+0.50%) ▲|AAPL342.93-1.24 (-0.36%) ▼|ABBV290.03+1.79 (+0.62%) ▲|ABT110.28-3.32 (-2.92%) ▼|ACN260.63-4.53 (-1.71%) ▼|ADBE239.54-6.90 (-2.80%) ▼|AMAT332.68+13.43 (+4.21%) ▲|AMD448.79+44.39 (+10.98%) ▲|AMGN460.74+0.46 (+0.10%) ▲|AMT189.86-4.14 (-2.13%) ▼|AMZN261.44+1.23 (+0.47%) ▲|AVGO292.85+1.32 (+0.45%) ▲|AXP321.54-3.43 (-1.06%) ▼|BA173.05+0.55 (+0.32%) ▲|BAC49.82+0.06 (+0.11%) ▲|BKNG162.34-6.38 (-3.78%) ▼|BLK1,183.11+12.44 (+1.06%) ▲|BMY62.88-0.25 (-0.40%) ▼|BNY148.47+0.98 (+0.66%) ▲|BRK-B573.20+0.87 (+0.15%) ▲|C119.98+1.53 (+1.29%) ▲|CAT556.69+3.05 (+0.55%) ▲|CL97.08-1.61 (-1.63%) ▼|CMCSA24.61-0.34 (-1.36%) ▼|COF201.52-2.33 (-1.14%) ▼|COP136.82+1.36 (+1.00%) ▲|COST1,061.45-4.15 (-0.39%) ▼|CRM215.13-7.28 (-3.27%) ▼|CSCO93.51-2.21 (-2.30%) ▼|CVS83.60+2.27 (+2.79%) ▲|CVX213.88+0.95 (+0.45%) ▲|DE673.69+10.38 (+1.56%) ▲|DHR229.76+3.42 (+1.51%) ▲|DIS117.22+0.00 (+0.00%) ▲|DUK128.65-1.43 (-1.10%) ▼|EMR161.75-0.87 (-0.53%) ▼|FDX308.12-8.69 (-2.74%) ▼|GD355.04-1.31 (-0.37%) ▼|GE322.41+7.68 (+2.44%) ▲|GEV759.68-10.83 (-1.41%) ▼|GILD168.07+0.50 (+0.30%) ▲|GM87.41-1.92 (-2.15%) ▼|GOOG284.24+2.50 (+0.89%) ▲|GOOGL285.31+2.74 (+0.97%) ▲|GS874.10+5.15 (+0.59%) ▲|HD344.50-5.45 (-1.56%) ▼|HON220.00+4.22 (+1.96%) ▲|IBM244.28-2.83 (-1.15%) ▼|INTC55.93+3.68 (+7.04%) ▲|INTU341.10-13.74 (-3.87%) ▼|ISRG454.33-14.20 (-3.03%) ▼|JNJ275.26+2.94 (+1.08%) ▲|JPM336.59-0.75 (-0.22%) ▼|KO96.27+0.54 (+0.56%) ▲|LIN518.36-2.87 (-0.55%) ▼|LLY1,368.38+3.65 (+0.27%) ▲|LMT571.98-4.18 (-0.73%) ▼|LOW225.22-2.02 (-0.89%) ▼|LRCX198.72+13.52 (+7.30%) ▲|MA657.52+1.60 (+0.24%) ▲|MCD277.65-0.39 (-0.14%) ▼|MDLZ66.50-0.32 (-0.48%) ▼|MDT102.58-2.26 (-2.16%) ▼|META617.42+12.34 (+2.04%) ▲|MMM187.05-0.72 (-0.38%) ▼|MO76.59-0.99 (-1.28%) ▼|MRK147.10+0.16 (+0.11%) ▲|MS183.12+0.68 (+0.37%) ▲|MSFT532.75-3.18 (-0.59%) ▼|MU682.73+26.34 (+4.01%) ▲|NEE87.54-0.72 (-0.81%) ▼|NFLX63.76-1.81 (-2.75%) ▼|NKE38.62-0.94 (-2.38%) ▼|NOW102.10-0.26 (-0.25%) ▼|NVDA185.84+4.24 (+2.34%) ▲|ORCL113.65-1.52 (-1.32%) ▼|PEP141.61-1.10 (-0.77%) ▼|PFE29.30-0.16 (-0.53%) ▼|PG166.01-1.09 (-0.65%) ▼|PLTR160.16+5.17 (+3.34%) ▲|PM199.55-1.96 (-0.97%) ▼|QCOM164.01+7.26 (+4.63%) ▲|RTX192.59+0.71 (+0.37%) ▲|SBUX105.79-0.37 (-0.35%) ▼|SCHW91.56-1.02 (-1.10%) ▼|SO92.48-0.87 (-0.93%) ▼|SPG228.46+1.91 (+0.84%) ▲|T21.70-0.12 (-0.55%) ▼|TMO696.33+19.39 (+2.86%) ▲|TMUS160.37-0.23 (-0.14%) ▼|TSLA358.50+14.81 (+4.31%) ▲|TXN275.91-2.24 (-0.81%) ▼|UBER69.02+0.24 (+0.35%) ▲|UNH394.96-0.77 (-0.19%) ▼|UNP291.92-6.04 (-2.03%) ▼|UPS108.31-2.73 (-2.46%) ▼|USB59.40-0.36 (-0.59%) ▼|V423.28+0.69 (+0.16%) ▲|VZ45.87-0.26 (-0.55%) ▼|WFC84.12-0.18 (-0.21%) ▼|WMT126.24-1.48 (-1.16%) ▼|XOM166.12+0.82 (+0.50%) ▲|
18.5 C
New York
Friday, November 6, 2026

Tag: form

newsFORsourcecompanycontentinformationreleases1market

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Happiness is the new brand currency: 8 in 10 Asia Pacific consumers rely on brands for unique, transformative experiences

Younger generations in Asia Pacific — Millennials (89%) and Gen Z (86%) — are driving the shift towards experiential brand engagement in the transformation...

TotalEnergies ENEOS solarizes Lee Huat Yap Kee’s logistics facilities in Singapore

SINGAPORE, July 8, 2025 /PRNewswire/ -- TotalEnergies ENEOS has successfully commissioned two solar rooftop photovoltaic (PV) systems for Lee Huat Yap Kee Pte Ltd (LHYK),...

Fluence Chosen for 300 MW / 600 MWh Wellington Battery Energy Storage System for AMPYR Australia

The project will include the full suite of Fluence’s innovative storage products, including Gridstack™, a 20-year service contract, Mosaic bidding software, and Nispera asset performance management software

Johnson & Johnson Launches VARIPULSE™ Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency,...

The Keg Royalties Income Fund Announces Receipt of Interim Order and Filing of Special Meeting Materials in Respect of Proposed Transaction with Fairfax

Not for distribution to U.S. News wire services or dissemination in the U.S.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apple Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAPL

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the “Class Period”), of the important August 19, 2025 lead plaintiff deadline.

China Airlines and The New Terminal One Announce Strategic Partnership, Transforming Customer Experience in New York City

TAIPEI,Taiwan and NEW YORK, July 7, 2025 /PRNewswire/ -- China Airlines (CAL), a Taiwan-based carrier, will begin operations at The New Terminal One at New...

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DDD

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline.

Bravo Reports Results of Preliminary Economic Assessment for its Luanga PGM+Au+Ni Project

VANCOUVER, BC, July 7, 2025 /CNW/ - Bravo Mining Corp. (TSXV: BRVO) (OTCQX: BRVMF), ("Bravo" or the "Company") is pleased to announce results of an...

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance

ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both Dr. Misra and Mr. Huang will report directly to Dajun Yang, M.D., Ph.D., the Company’s Chairman & Chief Executive Officer.

Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon

Los Angeles, CA , July 07, 2025 (GLOBE NEWSWIRE) -- Luma Nutrition is proud to announce that its flagship product, Luma Nutrition Magnesium Glycinate 1000mg, has officially surpassed 10,000 units sold per month on Amazon. As one of the best magnesium glycinate supplements available in 2025, this high-absorption formula continues to earn praise for its purity, effectiveness, and ability to support restful sleep, mental clarity, and full-body relaxation. 

INTERRENT REIT ANNOUNCES END OF “GO-SHOP” PERIOD

OTTAWA, ON, July 7, 2025 /CNW/ - InterRent Real Estate Investment Trust ("InterRent" or the "REIT") (TSX: IIP.UN) announced today the expiration of the...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsForm

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers